Skip to content

Supplier News

Johnson & Johnson to acquire Alios BioPharma

Johnson & Johnson plans to buy Alios BioPharma Inc., a clinical-stage biopharmaceutical company focused on developing therapies for viral diseases, for $1.75 billion in cash. J&J said Tuesday that the acquisition will bolster its current pipeline for viral diseases.

Coty CEO Scannavini resigns

Michele Scannavini has stepped down as Coty Inc. chief executive officer and resigned from the company’s board of directors. Michele Scannavini Coty said Monday that Scannavini’s departure was due to personal reasons.

Dr. Reddy’s launches Xopenex generic

Dr. Reddy’s Laboratories has rolled out levalbuterol inhalation solution, a bronchodilator medication. The company said Wednesday that its levalbuterol inhalation product is a generic version of Xopenex (levalbuterol hydrochloride) from Sunovion Pharmaceuticals Inc. Dr.

Zim’s adds vapor rub to health care lineup

Zim’s has expanded its product roster with the introduction of Zim’s Advanced Vapor Rub. Perfecta Products Inc., the maker of the brand, said Wednesday that the vapor rub come in two forms: a traditional jar and a four-ounce tube with a no mess, easy-on applicator. The company noted that the tube